×

Dr. Subramanian Murali

Dr. Subramanian Murali

Dr. Subramanian Murali

QualificationMBBS, MD (General Medicine), DM (Medical Oncology)

SpecialitiesMedical Oncology

Locations HCG Hospital, Hebbal
Experience24 years
Book an Appointment
SELECT DATE
AVAILABLE SLOTS

Introduction

Dr. Murali Subramanian is a highly accomplished Medical Oncologist with over two decades of experience in delivering advanced, evidence-based cancer care. He specializes in the management of both solid tumors and hematological malignancies, with expertise in chemotherapy, targeted therapy, and immunotherapy.

A pioneer in oncology services, he has been instrumental in establishing one of the first dedicated Day Care Chemotherapy Infusion Centres in Bangalore, significantly enhancing accessibility, efficiency, and patient comfort in cancer treatment.

Has vast clinical experience and has been associated with several prestigious institutions in the past, including Columbia Asia Hospital, Manipal Hospitals, Aster CMI Hospital, and Bangalore Baptist Hospital.

Dr. Murali believes in delivering personalized, evidence-based cancer care, with a strong emphasis on patient well-being, quality of life, and clear communication throughout the treatment journey.

Area of Expertise

  • Dr. Murali Subramanian is a Senior Consultant - Medical Oncology and Director of HCG Day Care Chemotherapy Centers at HCG Cancer Hospital, Bangalore.

  • His key areas of expertise include:

  1. Comprehensive management of solid tumors and hematological cancers

  2. Systemic therapies: Chemotherapy, Targeted Therapy, Immunotherapy

  3. Specialized procedures, including bone marrow aspiration, intrathecal, and intraperitoneal chemotherapy

  4. Management of advanced and complex malignancies

Research & Publications

·         Unusual Case of Pulmonary and Hepatic Metastases of Mandibular Ameloblastoma - Indian Journal Of Medical & Paediatric Oncology Vol. 28, No 3, 2007

·         Embryonal Rhabdomyosarcoma of Chest wall: a case report and review of literature - Indian Journal of Pathology and Microbiology, 51(2) April-June 2008.

·         Rituximab induced Subacute Interstitial Pneumonitis: A case report and review of literature - Journal of Cancer Research and Therapeutics July – Sept 2010 Vol 6 Issue 

·         Membranoproliferative Glomerulonephritis Secondary to Chronic Myeloid Leukaemia - Saudi Journal of Kidney Disease and Transplantation 2010 21(4) 738-741

·         A Rare case of Papillary Carcinoma of Choroid Plexus: Its management and review of literature - Indian Journal of Medical and Paediatric Oncology April – June 2011 Vol 32 Issue 2.

·         The technique of Intraperitoneal Chemotherapy using Veress needle in patients with Ovarian Cancer - International Journal of Gynaecological Cancer Vol 2, number 8, November 2011.

·         Feasibility of concurrent weekly Paclitaxel and Radiotherapy in Node-Positive Breast Cancer: An experience from Indian Journal of Clinical Oncology, 2012 Breast Cancer Symposium - Vol 30, No 27 Supplement (September 20 supplement), 2012

·         Relapsed Hodgkin's Lymphoma presenting as an isolated ulcerative lesion of the base of tongue - Indian Journal of Haematology and Blood transfusion 2014 30:349-352.

·         Unusual Aetiology of Secondary Thyrotoxicosis and its presentation - South Asian Journal of Cancer. Year: 2015 | Volume: 4 | Issue Number: 1 | Page: 46-47 

·         Rituximab Induced Interstitial Lung Disease in Patients with Non-Hodgkin’s Lymphoma: A Clinical Study of Six Cases and Review of the Literature – Lymphoma Volume 2014 (2014), Article ID 160421, 6 pages

·         Incidence of Kirsten-ras gene mutation and its association with Clinical and Pathological factors in Colorectal Carcinoma: Single Institute Retrospective Experience - Annals of Oncology Vol 25 Issue supplement 2 pp ii65 (poster presentation).

·         Imatinib induced Pemphigus Foliaceus in Patients with GIST- Current Medical Issues 2020;18:245-7

 

Medical Breakthrough

  • Dr. Murali is the pioneer and has been instrumental in setting up the first dedicated Day Care Chemo Infusion Centres in Bangalore – Karnataka.

Awards & Accolades

Academic & Research Contributions

Dr. Murali has made significant contributions to oncology through peer-reviewed publications, clinical research, and academic mentorship. His work focuses on rare tumor presentations, atypical metastatic patterns, treatment-related toxicities, innovative chemotherapy delivery techniques, and real-world clinical outcomes.

He has authored multiple publications in reputed journals, including Annals of Oncology, Journal of Cancer Research and Therapeutics, and Indian Journal of Medical & Paediatric Oncology. His research has been presented at international platforms such as ASCO, with academic contributions aligned with high-impact journals like JCO.

Leadership & Experience

  • Former Professor, Department of Medical Oncology – M.S. Ramaiah Medical College

  • Actively involved in undergraduate and postgraduate medical training

  • Co-guide for postgraduate research in oncology-related disciplines

  • Medical Director – Oncology India Day Care Centres, Bangalore

  • Director, HCG Day Care Chemotherapy Centres, Bangalore

Awards

  • GCRI Award for Outstanding Academic Achievement (2005)

Other Doctors

Didn't find what you were looking for?

Feel free to reach out to us.

+91
Or reach us directly
Chat With Us
WhatsApp Icon